Genome-wide scan and fine-mapping of rare nonsynonymous associations implicates intracellular lipolysis genes in fat distribution and cardio-metabolic risk

Difficulties in identifying causal variants and genes underlying genetic associations have limited the translational potential of genetic studies of body fat distribution, an important, partly-heritable risk factor for cardio-metabolic disease. Rare variant associations facilitate fine-mapping of causal alleles, but their contribution to fat distribution is understudied. We performed a genome-wide scan of rare nonsynonymous variants for body mass index-adjusted waist-to-hip-ratio (BMI-adjusted WHR; a widely-used measure of fat distribution) in 450,562 European ancestry individuals, followed by systematic Bayesian fine-mapping at six genome-wide (p<5×10−08; main-analysis) and two subthreshold signals (significant at a Bonferroni-corrected p<1.3×10−06). We found strong statistical evidence of causal association for nonsynonymous alleles in CALCRL (p.L87P, pconditional=5.9×10−12; posterior-probability of association [PPA]=52%), PLIN1 (p.L90P, pconditional=5.5×10−13; PPA>99%), PDE3B (p.R783X, pconditional=6.2×10−15; PPA>99%), ACVR1C (p.I195T; pconditional=5.4×10−12; PPA>99%), and FGF1 (p.G21E, pconditional=1.6×10−07; PPA=98%). Alleles at the four likely-causal main-analysis genes affected fat distribution primarily via larger hip-rather than smaller waist-circumference and six of nine conditionally-independent WHR-lowering index-variants were associated with protection from cardiovascular or metabolic disease. All four genes are expressed in adipose tissue and have been linked with the regulation of intracellular lipolysis, which controls fat retention in mature cells. Targeted follow-up analyses of key intracellular-lipolysis genes revealed associations for a variant in the initiator of intracellular lipolysis PNPLA2 (p.N252K) with higher BMI-adjusted-WHR and higher cardio-metabolic risk. This study provides human genetic evidence of a link between intracellular lipolysis, fat-distribution and its cardio-metabolic complications in the general population.

[1]  Richard G. Lee,et al.  Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides , 2017, The New England journal of medicine.

[2]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[3]  G. Yancopoulos,et al.  Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. , 2012, The New England journal of medicine.

[4]  M. Birnbaum,et al.  The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin , 2015, Molecular and Cellular Biology.

[5]  Johannes Söding,et al.  The MPI bioinformatics Toolkit as an integrative platform for advanced protein sequence and structure analysis , 2016, Nucleic Acids Res..

[6]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[7]  C A Emdin,et al.  Apfeltyp erhöht Diabetes- und KHK-Risiko , 2017, DMW - Deutsche Medizinische Wochenschrift.

[8]  S. O’Rahilly,et al.  Genetic syndromes of severe insulin resistance. , 2011, Endocrine reviews.

[9]  J. Granneman,et al.  Perilipin Controls Lipolysis by Regulating the Interactions of AB-hydrolase Containing 5 (Abhd5) and Adipose Triglyceride Lipase (Atgl)* , 2009, The Journal of Biological Chemistry.

[10]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[11]  O. Smithies,et al.  Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene , 2006, Molecular and Cellular Biology.

[12]  北村 聖 "The New England Journal of Medicine". , 1962, British medical journal.

[13]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2007, Current protocols in protein science.

[14]  M. Belfort,et al.  Targeting Adrenomedullin to Improve Lipid Homeostasis in Diabetic Pregnancies , 2017, The Journal of clinical endocrinology and metabolism.

[15]  Cathie Sudlow,et al.  Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank , 2016, PloS one.

[16]  Ralf Herwig,et al.  Analyzing and interpreting genome data at the network level with ConsensusPathDB , 2016, Nature Protocols.

[17]  Frank Eisenhaber,et al.  Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase , 2004, Science.

[18]  R. Zechner,et al.  A Peptide Derived from G0/G1 Switch Gene 2 Acts as Noncompetitive Inhibitor of Adipose Triglyceride Lipase* , 2014, The Journal of Biological Chemistry.

[19]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[20]  F. Kronenberg,et al.  Investigation and Functional Characterization of Rare Genetic Variants in the Adipose Triglyceride Lipase in a Large Healthy Working Population , 2010, PLoS genetics.

[21]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[22]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.

[23]  P. Munroe,et al.  Genetic Evidence for a Normal-Weight “Metabolically Obese” Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes , 2014, Diabetes.

[24]  Tanya M. Teslovich,et al.  Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.

[25]  J. Danesh,et al.  Association analyses based on false discovery rate implicate new loci for coronary artery disease , 2017, Nature Genetics.

[26]  N Slimani,et al.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.

[27]  J. M. Suh,et al.  Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer , 2014, Nature.

[28]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2016 .

[29]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[30]  M. McCarthy,et al.  Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity , 2014, Diabetes.

[31]  Inês Barroso,et al.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance , 2016, Nature Genetics.

[32]  Andrew D. Johnson,et al.  Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation , 2016, Nature Genetics.

[33]  Inês Barroso,et al.  Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.

[34]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[35]  S. O’Rahilly,et al.  Perilipin deficiency and autosomal dominant partial lipodystrophy. , 2011, The New England journal of medicine.

[36]  D. Gaudet,et al.  Targeting APOC3 in the familial chylomicronemia syndrome. , 2014, The New England journal of medicine.

[37]  T. Izumi,et al.  Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα , 2012, Diabetes.

[38]  B. Nordestgaard,et al.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.

[39]  D. Gaudet,et al.  ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia. , 2017, The New England journal of medicine.

[40]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[41]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[42]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[43]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[44]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[45]  J. M. Suh,et al.  A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis , 2012, Nature.

[46]  Sekar Kathiresan,et al.  Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.

[47]  F. Karpe,et al.  Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes , 2015, Nature Reviews Endocrinology.

[48]  H. Burdett Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia , 2016, Annals of clinical biochemistry.

[49]  R. Evans,et al.  FGF1 — a new weapon to control type 2 diabetes mellitus , 2017, Nature Reviews Endocrinology.

[50]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[51]  Tamara S. Roman,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.

[52]  R. Zechner,et al.  Cytosolic lipolysis and lipophagy: two sides of the same coin , 2017, Nature Reviews Molecular Cell Biology.

[53]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[54]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[55]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[56]  Jake K. Byrnes,et al.  Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.

[57]  G. Kempermann Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[58]  He Zhang,et al.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.

[59]  John H. Zhang,et al.  Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[60]  S. Kathiresan A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. , 2008, The New England journal of medicine.

[61]  Mark Woodward,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[62]  Peter Kraft,et al.  Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. , 2015, American journal of human genetics.

[63]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[64]  Chris Cain ALK7's obese functions , 2014 .

[65]  Peter Johnson,et al.  Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6 , 2011, Human mutation.

[66]  P. Donnelly,et al.  Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.

[67]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[68]  B. Berger,et al.  Efficient Bayesian mixed model analysis increases association power in large cohorts , 2014, Nature Genetics.

[69]  Tom R. Gaunt,et al.  Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.

[70]  E. Degerman,et al.  From PDE3B to the regulation of energy homeostasis. , 2011, Current opinion in pharmacology.

[71]  Jing Wang,et al.  CrossMap: a versatile tool for coordinate conversion between genome assemblies , 2014, Bioinform..

[72]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[73]  S. Raychaudhuri Mapping Rare and Common Causal Alleles for Complex Human Diseases , 2011, Cell.

[74]  D. Mikhailidis,et al.  Cilostazol for intermittent claudication. , 2014, The Cochrane database of systematic reviews.

[75]  Y. Sakata,et al.  A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: A case report and literature review , 2014, Neuromuscular Disorders.

[76]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[77]  Alex P. Reiner,et al.  Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .

[78]  R. Frikke-Schmidt,et al.  Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease , 2014 .

[79]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[80]  D. Gaudet,et al.  Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. , 2015, The New England journal of medicine.

[81]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[82]  D. Turnbull,et al.  The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene , 2011, Journal of Neurology.

[83]  J. Danesh,et al.  ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.

[84]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[85]  S. Crooke,et al.  Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials , 2016, The Lancet.

[86]  J. Granneman,et al.  Novel Pharmacological Probes Reveal ABHD5 as a Locus of Lipolysis Control in White and Brown Adipocytes , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[87]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[88]  Richard Durbin,et al.  Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins , 2014, Nature Genetics.

[89]  S. Bernard,et al.  Dynamics of human adipose lipid turnover in health and metabolic disease , 2011, Nature.

[90]  Kristin G Ardlie,et al.  Genetic Analysis in UK Biobank Links Insulin Resistance and Transendothelial Migration Pathways to Coronary Artery Disease , 2017, Nature Genetics.

[91]  Anders Albrechtsen,et al.  Weighting sequence variants based on their annotation increases power of whole-genome association studies , 2016, Nature Genetics.

[92]  Giovanni Malerba,et al.  Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes , 2017, Nature Genetics.

[93]  M. Lathrop,et al.  The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy , 2007, Nature Genetics.

[94]  M. Gerstein,et al.  AlleleSeq: analysis of allele-specific expression and binding in a network framework , 2011, Molecular systems biology.

[95]  E. Bertini,et al.  Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients , 2017, Orphanet Journal of Rare Diseases.

[96]  Jeffrey R O'Connell,et al.  Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. , 2014, The New England journal of medicine.

[97]  P. Arner,et al.  Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. , 2014, The Journal of clinical endocrinology and metabolism.

[98]  Gaston H. Gonnet,et al.  The OMA orthology database in 2015: function predictions, better plant support, synteny view and other improvements , 2014, Nucleic Acids Res..

[99]  Alan M. Kwong,et al.  A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.

[100]  Eric Boerwinkle,et al.  Sequence Variations in PCSK 9 , Low LDL , and Protection against Coronary Heart Disease , 2006 .

[101]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[102]  R. Zechner,et al.  Development of small molecule inhibitors targeting adipose triglyceride lipase , 2013, Nature chemical biology.

[103]  C. Diwoky,et al.  Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice , 2017, Nature Communications.

[104]  Samuel E. Jones,et al.  Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease , 2016, Diabetes.

[105]  A. Garg Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[106]  R. BailénAlmorox Effect of a monoclonal antibody to PCSK9 on LDL cholesterol , 2012 .

[107]  S. O’Rahilly,et al.  Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-hydrolase-containing 5 (ABHD5)* , 2011, The Journal of Biological Chemistry.

[108]  Mary E. Haas,et al.  Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease , 2018, Nature Communications.

[109]  R. Zechner,et al.  Measurement of lipolysis. , 2014, Methods in enzymology.

[110]  T. Consortium Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011 .